View:
Download DOC
Download PDF
Download XLS
FORM 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

 
OMB APPROVAL

[   ] Check this box if no longer
       subject to Section 16. Form 4 or
       Form 5 obligations may continue.
       See Instruction 1(b).

Washington, D.C. 20549
 
STATEMENT OF CHANGES IN

OMB Number                  3235-0287
Expires:             December 31, 2001
Estimated average burden
hours per response                      0.5

(Print or Type Responses)

BENEFICIAL OWNERSHIP

 
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility
Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940

1.    Name and Address of Reporting Person*
 
Estes,                        V.                           Dean
        (Last)                                        (First)                                   (Middle)		 4.    Statement for Month/Year
 
    May 2002

 
 
 
9341 Courtland Drive, N.E.
                                                        (Street)

 5.    If Amendment, Date of Original (Month/Year)
 
 
 
 
Rockford,                       MI                  49351
        (City)                                        (State)                                   (Zip)		  
2.    Issuer Name and Ticker or Trading Symbol  
 
     Wolverine World Wide, Inc. ("WWW")		 6.    Relationship of Reporting Person(s) to Issuer
                                    (Check all applicable)
             Director                                          10% Owner
  X       Officer (give title                            Other (specify below)
                           below)
                      Vice President 
3.    I.R.S. or Social Security Number of Reporting Person (Voluntary)
 
 		 7.    Individual or Joint/Group Filing (Check Applicable Line)
           X     Form Filed by One Reporting Person
                   Form Filed by More than One Reporting Person

 
Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
 
1. Title of Security
    (Instr. 3)		 2. Transaction
    Date
    (Month/
    Day/
    Year)		 3. Transaction
    Code
    (Instr. 8)		 4. Securities Acquired (A)
    or Disposed of (D)
    (Instr. 3, 4 and 5)		 5. Amount of
    Securities
    Beneficially
    Owned at
    End of
    Month
    (Instr. 3
    and 4)		 6. Ownership
    Form: Di-
    rect (D) or
    Indirect (I)
    (Instr. 4)		 7. Nature of
    Indirect
    Beneficial
    Ownership
    (Instr. 4)
    Code V Amount (A) or (D) Price      
 Common Stock
2/14/02
 A V 5,000 A N/A see below
D
  
 Common Stock
2/23/02
 F V 1,665 D $15.575 see below
D
  
 Common Stock
2/24/02
F
V
 1,627
D
 $15.935 see below
D
  
 Common Stock
2/25/02
F
V
 276
D
 $15.935 see below
D
  
 Common Stock
3/3/02
F
V
 552
D
 $15.90 see below
D
  
 Common Stock
5/8/02
M
 
 10,500
A
 $7.09877 see below
D
  
 Common Stock
5/8/02
F
V
 4,079
D
 $18.275 see below
D
  
Common Stock
4/5/02
G
V
125
D
N/A
86,017
D
  
                   
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

  Potential persons who are to respond to the collection of Information contained in this form are not required to respond unless the form displays a currently valid OMB control number.


Form 4 (continued) Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)		  
1. Title of Derivative Security
    (Instr. 3)		 2. Conversion
    or Exercise
    Price of
    Derivative
    Security		 3. Transaction
    Date
    (Month/
    Day/
    Year)		 4. Transaction
    Code
    (Instr. 8)		 5. Number of Deriva-
    tive Securities Ac-
    quired (A) or Dis-
    posed of (D)
    (Instr. 3, 4, and 5)		 6. Date Exercisable
    and Expiration Date
    (Month/Day/Year)
       
Code		  
V		  
(A)		  
(D)		 Date
Exercisable		 Expiration
Date
Stock Option (Right to Buy)
$15.44
 2/14/02 A V 3,375   2/14/02 2/13/12
 
$15.44
 2/14/02 A V 3,375   2/14/03 2/13/12
 
$15.44
 2/14/02 A V 3,375   2/14/04 2/13/12
 
$15.44
 2/14/02 A V 3,375   2/14/05 2/13/12
 
 
              
Stock Option (Right to Buy)
$15.575
 2/23/02 A V 1,228   2/23/02 2/22/09
Stock Option (Right to Buy)
$15.935
 2/24/02 A V 610   2/24/02 2/23/07
Stock Option (Right to Buy)
$15.935
 2/24/02 A V 589   2/24/02 2/23/10
Stock Option (Right to Buy)
$15.935
 2/25/02 A V 203   2/25/02 2/24/08
Stock Option (Right to Buy)
$15.90
 3/3/02 A V 407   3/3/02 3/2/09
Stock Option (Right to Buy)(1)
$7.09877
 5/8/02 M     6,329 3/10/94 3/9/04
 
$7.09877
 5/8/02 M     4,171 3/10/95 3/9/04
 
$7.09877
           3/10/96 3/9/04
 
$7.09877
           3/10/97 3/9/04
 
 
              


7. Title and Amount of
Underlying Securities (Instr. 3 and 4)		 8. Price of Derivative Securitie(Instr. 5) 9. Number of derivative Securities Beneficially Owned at End of Month (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
 Title
Amount of Number of Shares
      
  
Common Stock
3,375
N/A
3,375
 D  
Common Stock
3,375
N/A
3,375
 D  
Common Stock
3,375
N/A
3,375
 D  
Common Stock
3,375
N/A
3,375
 D  
 
 
 
 
    
Common Stock
1,228
N/A
1,228
 D  
Common Stock
610
N/A
610
 D  
Common Stock
589
N/A
589
 D  
Common Stock
203
N/A
203
 D  
Common Stock
407
N/A
407
 D  
Common Stock
6,329
N/A
0
 D  
Common Stock
6,329
N/A
2,158
 D  
Common Stock
6,329
N/A
6,329
 D  
Common Stock
6,327
N/A
6,327
 D  
 
 
 
 
    
           

Explanation of Responses:

(1) Shares and prices have been adjusted to reflect stock splits.

**Intentional misstatements or omissions of facts constitute   /s/ V. Dean Estes*   June 7, 2002
    Federal Criminal Violations.   **Signature of Reporting Person   Date
    See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).  
               V. Dean Estes
                By Jeffrey A. Ott
                Attorney-in-Fact  
    


Note: File three copies of this Form, one of which must be manually signed.
          If space provided is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not
required to respond unless the form displays a currently valid OMB Number.



POWER OF ATTORNEY

                    The undersigned, a director and/or officer of Wolverine World Wide, Inc., a Delaware corporation (the "Company"), does hereby nominate, constitute and appoint Blake W. Krueger, Stephen L. Gulis, Jr. and Jeffrey A. Ott, or any one or more of them, his or her true and lawful attorneys and agents to do any and all acts and things and to execute and file any and all instruments which such attorneys and agents, or any of them, may deem necessary or advisable to enable the undersigned (in his or her individual capacity or in a fiduciary or other capacity) to comply with the Securities Exchange Act of 1934, as amended (the "Act"), and any requirements of the Securities and Exchange commission in respect thereof, in connection with the preparation, execution and filing of any report or statement of beneficial ownership or changes in beneficial ownership of securities of the Company that the undersigned (in his or her individual capacity or in a fiduciary or other capacity) may be required to file pursuant to Section 16(a) of the Act including, without limitation, full power and authority to sign the undersigned's name, in his or her individual capacity or in a fiduciary or other capacity, to any report or statement on Form 3, 4 or 5, or to any amendments or any successor forms thereto, or any form or forms adopted by the Securities and Exchange Commission in lieu thereof or in addition thereto, hereby ratifying and confirming all that such attorneys and agents, or any of them, shall do or cause to be done by virtue hereof.

                    The undersigned agrees that the attorneys-in-fact named herein may rely entirely on information furnished orally or in writing by the undersigned to such attorneys-in-fact. The undersigned also agrees to indemnify and hold harmless the Company and the attorneys-in-fact against any losses, claims, damages or liabilities (or actions in respect thereof) that arise out of or are based upon any untrue statement or omission of necessary fact in the information provided by the undersigned to the attorneys-in-fact for purposes of executing, acknowledging, delivering or filing Forms 3, 4, or 5, or any amendments or any successor forms thereto, or any form or forms adopted by the Securities and Exchange Commission in lieu thereof or in addition thereto, and agrees to reimburse the Company and the attorneys-in-fact herein for any legal or other expenses reasonably incurred in connection with investigating or defending against any such loss, claim, damage, liability or action.

                    This authorization shall supersede all prior authorizations to act for the undersigned with respect to securities of the Company in these matters, which prior authorizations are hereby revoked, and shall survive the termination of the undersigned's status as a director and/or officer of the Company and remain in effect thereafter for so long as the undersigned (in his or her individual capacity or in a fiduciary or other capacity) has any obligation under Section 16 of the Act with respect to securities of the Company.

Date:

        5/8/95

/s/  V. Dean Estes

   

     V. Dean Estes